Sanofi Revenue per Employee (SNY), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Sanofi  (NASDAQ: SNY)
 

Sanofi's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 5.49% in the fourth quarter 2025, year on year to cumulative value of $52,321 million, Sanofi's revenue per employee grew on a trailing twelve months basis to $ 22,927,713, this marks a new company high.
Within the Healthcare sector Employees of 2 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 67, from total ranking in previous quarter at 898. Sanofi has 2,282 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SNY Revenue per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Revenue Change 5.49 % - - - -4.65 %
Sales per Employee (TTM) $ 22,927,713 21,735,197 21,735,197 21,735,197 21,735,197
SNY's Total Ranking # 67 # 898 # # #
Seq. Revenue Change - - - - -

SNY Company Profile >> Back to SNY Efficiency Comparisons >> Compare SNY Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 3
Healthcare Sector # 3
Overall Market # 67

Revenue per Employee Statistics
High Average Low
$ 22,927,713 $ 20,579,169 $ 17,510,184
(Dec 31 2025)   (Dec 31 2018)



Financial Statements
Sanofi's Revenue MRQ $ 52,321 Millions Visit SNY's Income Statement
Sanofi's Revenues TTM $ 52,321 Millions Visit SNY's aggregate revenue growth
What are SNY's Sales? Visit SNY's Sales by Segment


  News about Sanofi Revenue per employee

Red Flags Raised Pomerantz Law Firm Probes Sanofi Amid Investor Concerns,

NEW YORK, July 18, 2025 - Pomerantz LLP, a prominent national law firm, has announced its investigation into claims on behalf of investors of Sanofi (NASDAQ: SNY), the multinational biopharmaceutical company. This investigation emerges amidst growing concerns regarding issues surrounding the company’s performance and its impact on investor confidence. If you are an investor in Sanofi, it is crucial to stay informed about developments that could influence your investments. The Context of the InvestigationInvestors may find themselves questioning the financial health and operational strategies of Sanofi. While revenue from Sanofi’s corporate clients has seen fluctuations, the company’s overall market performance has raised red flags for shareholders. Increased scrutiny on Sanofi s internal operations, drug development pipelines, and regulatory challenges has left many investors wary of their financial commitments to the company.



Other Ratios
Sanofi's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SNY's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SNY's Competitors
Revenue per Employee for SNY's Suppliers
Revenue per Employee for SNY's Customers

You may also want to know
SNY's Sales Growth Rates SNY's Pe Price to earnings ratio SNY's Receivables Turnover Ratio SNY's Stock Quote
SNY's Net Income Growth Rates SNY's Ps Price to Sales ratio SNY's Sales per Employee SNY's Asset Turnover Ratio
SNY's Net Margin SNY's Pb Price to Book ratio SNY's Financial Strength Ratios SNY's Dividend Payout Ratio
Date modified: 2026-06-24T10:07:58+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Vertex Pharmaceuticals Inc  29,632,839.51 $ 12,001.300  Million 405 
Royalty Pharma Plc  23,781,930.00 $ 2,378.193  Million 100 
Sanofi  22,927,712.53 $ 52,321.040  Million 2,282 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.